UPDATE: Assertio Therapeutics Q3 Adj. EPS $0.22 Beats $0.07 Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $34.21 million which beat the analyst consensus estimate of $31.33 million by 9.20 percent. This is a 34.31 percent increase over sales of $25.47 million the same period last year.

Total
0
Shares
Related Posts
Read More

Microsoft Introduces New AI-Powered Features At Build Conference: What You Need To Know

Microsoft Corporation (NASDAQ: MSFT) kicked off its annual Build developer conference on Tuesday. The three-day event, which started with a keynote from CEO Satya Nadella, is focused on providing developers with in-depth sessions on the latest tools and features for Windows 11 and Microsoft 365. This year, a significant emphasis is on new AI innovations and enhancements.

MSFT